What are the predictors that affect the excellent long-term benefits of redo coronary artery bypass grafting?

Ayyaz Ali1, Darryl Ramoutar, Hutan Ashrafian

  • 1Department of Cardiothoracic Surgery, Papworth Hospital, Papworth Everard, Cambridge, United Kingdom.

Insights

Redo coronary artery bypass grafting (CABG) offers acceptable long-term survival and symptom relief for patients with recurrent angina. However, specific risk factors like poor left ventricular function and radial artery graft use require careful consideration.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Coronary Artery Disease Management

Background:

  • Recurrent angina after initial coronary artery bypass grafting (CABG) often necessitates repeat surgical revascularization.
  • Managing patients with refractory angina post-CABG presents significant clinical challenges.

Purpose of the Study:

  • To evaluate the long-term survival and freedom from cardiac events following redo CABG.
  • To identify predictors of surgical efficacy and adverse outcomes in repeat revascularization procedures.

Main Methods:

  • Retrospective analysis of 101 patients undergoing redo CABG between 1996 and 2004.
  • Kaplan-Meier survival analysis and Cox proportional hazards modeling for risk factor identification.
  • Composite endpoint defined as angina class ≥2, NYHA class ≥2, myocardial infarction, or need for percutaneous intervention.

Main Results:

  • 30-day mortality was 1.2%; mean follow-up was 5.3 years.
  • Poor left ventricular function and pre-operative NYHA class ≥2 independently predicted decreased survival.
  • Radial artery graft use was associated with increased peri-operative death (OR=18).
  • Actuarial survival at 8 years was 76.9%; freedom from cardiac events at 8 years was 68%.

Conclusions:

  • Redo CABG provides acceptable short- and long-term survival and symptom relief at a single institution.
  • Pre-operative patient factors significantly influence outcomes.
  • The association between radial artery grafts and adverse early outcomes requires further investigation.
Abstract